Exosomes Derived from Pancreatic Cancer Cells Induce Osteoclast Differentiation Through the miR125a-5p/TNFRSF1B Pathway

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.21590
   PubMed Web of Science ®Google Scholar
• Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. Lancet. 2020;395(10242):2008–2020. doi:10.1016/S0140-6736(20)30974-0
   PubMed Web of Science ®Google Scholar
• Ilic M, Ilic I. Epidemiology of pancreatic cancer. World J Gastroenterol. 2016;22(44):9694–9705. doi:10.3748/wjg.v22.i44.9694
   PubMed Web of Science ®Google Scholar
• Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KCH. Cancer-associated cachexia. Nat Rev Dis Primers. 2018;4(1):17105. doi:10.1038/nrdp.2017.105
   PubMed Web of Science ®Google Scholar
• Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489–495. doi:10.1016/S1470-2045(10)70218-7
   PubMed Web of Science ®Google Scholar
• Peng P, Hyder O, Firoozmand A, et al. Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. J Gastrointest Surg. 2012;16(8):1478–1486. doi:10.1007/s11605-012-1923-5
   PubMed Web of Science ®Google Scholar
• Sandini M, Bernasconi DP, Fior D, et al. A high visceral adipose tissue-to-skeletal muscle ratio as a determinant of major complications after pancreatoduodenectomy for cancer. Nutrition. 2016;32(11–12):1231–1237. doi:10.1016/j.nut.2016.04.002
   PubMed Web of Science ®Google Scholar
• von Haehling S, Anker MS, Anker SD. Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016. J Cachexia Sarcopenia Muscle. 2016;7(5):507–509. doi:10.1002/jcsm.12167
   PubMed Web of Science ®Google Scholar
• Sah RP, Nagpal SJ, Mukhopadhyay D, Chari ST. New insights into pancreatic cancer-induced paraneoplastic diabetes. Nat Rev Gastroenterol Hepatol. 2013;10(7):423–433. doi:10.1038/nrgastro.2013.49
   PubMed Web of Science ®Google Scholar
• Imoto A, Mitsunaga S, Inagaki M, et al. Neural invasion induces cachexia via astrocytic activation of neural route in pancreatic cancer. Int J Cancer. 2012;131(12):2795–2807. doi:10.1002/ijc.27594
   PubMed Web of Science ®Google Scholar
• Fearon KC. The Sir David Cuthbertson Medal lecture 1991. The mechanisms and treatment of weight loss in cancer. Proc Nutr Soc. 1992;51(2):251–265. doi:10.1079/PNS19920036
   PubMed Web of Science ®Google Scholar
• Choi E, Carruthers K, Zhang L, et al. Concurrent muscle and bone deterioration in a murine model of cancer cachexia. Physiol Rep. 2013;1(6):e00144. doi:10.1002/phy2.144
   PubMedGoogle Scholar
• Zhang Q, Sun X, Yang J, et al. ZIP4 silencing improves bone loss in pancreatic cancer. Oncotarget. 2015;6(28):26041–26051. doi:10.18632/oncotarget.4667
   PubMedGoogle Scholar
• Bonetto A, Kays JK, Parker VA, et al. Differential bone loss in mouse models of colon cancer cachexia. Front Physiol. 2016;7:679.
   PubMed Web of Science ®Google Scholar
• Tkach M, Thery C. Communication by extracellular vesicles: where we are and where we need to go. Cell. 2016;164(6):1226–1232. doi:10.1016/j.cell.2016.01.043
   PubMed Web of Science ®Google Scholar
• Milane L, Singh A, Mattheolabakis G, Suresh M, Amiji MM. Exosome mediated communication within the tumor microenvironment. J Control Release. 2015;219:278–294. doi:10.1016/j.jconrel.2015.06.029
   PubMed Web of Science ®Google Scholar
• Tesfaye AA, Azmi AS, Philip PA. miRNA and gene expression in pancreatic ductal adenocarcinoma. Am J Pathol. 2019;189(1):58–70. doi:10.1016/j.ajpath.2018.10.005
   PubMed Web of Science ®Google Scholar
• Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12(12):861–874. doi:10.1038/nrg3074
   PubMed Web of Science ®Google Scholar
• Lan B, Zeng S, Grutzmann R, Pilarsky C. The role of exosomes in pancreatic cancer. Int J Mol Sci. 2019;20(18):4332. doi:10.3390/ijms20184332
   PubMed Web of Science ®Google Scholar
• Javeed N, Sagar G, Dutta SK, et al. Pancreatic cancer-derived exosomes cause paraneoplastic beta-cell dysfunction. Clin Cancer Res. 2015;21(7):1722–1733. doi:10.1158/1078-0432.CCR-14-2022
   PubMed Web of Science ®Google Scholar
• Sagar G, Sah RP, Javeed N, et al. Pathogenesis of pancreatic cancer exosome-induced lipolysis in adipose tissue. Gut. 2016;65(7):1165–1174. doi:10.1136/gutjnl-2014-308350
   PubMed Web of Science ®Google Scholar
• Wang L, Zhang B, Zheng W, et al. Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway. Sci Rep. 2017;7(1):5384. doi:10.1038/s41598-017-05541-4
   PubMed Web of Science ®Google Scholar
• Faict S, Muller J, De Veirman K, et al. Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts. Blood Cancer J. 2018;8(11):105. doi:10.1038/s41408-018-0139-7
   PubMed Web of Science ®Google Scholar
• Raimondi L, De Luca A, Amodio N, et al. Involvement of multiple myeloma cell-derived exosomes in osteoclast differentiation. Oncotarget. 2015;6(15):13772–13789. doi:10.18632/oncotarget.3830
   PubMed Web of Science ®Google Scholar
• Sun L, Lian JX, Meng S. MiR-125a-5p promotes osteoclastogenesis by targeting TNFRSF1B. Cell Mol Biol Lett. 2019;24(1):23. doi:10.1186/s11658-019-0146-0
   PubMed Web of Science ®Google Scholar
• Singhi AD, Koay EJ, Chari ST, Maitra A. Early detection of pancreatic cancer: opportunities and challenges. Gastroenterology. 2019;156(7):2024–2040. doi:10.1053/j.gastro.2019.01.259
   PubMed Web of Science ®Google Scholar
• Linton SS, Abraham T, Liao J, et al. Tumor-promoting effects of pancreatic cancer cell exosomes on THP-1-derived macrophages. PLoS One. 2018;13(11):e0206759. doi:10.1371/journal.pone.0206759
   PubMed Web of Science ®Google Scholar
• Su MJ, Aldawsari H, Amiji M. Pancreatic cancer cell exosome-mediated macrophage reprogramming and the role of micro-RNAs 155 and 125b2 transfection using nanoparticle delivery systems. Sci Rep. 2016;6(1):30110. doi:10.1038/srep30110
   PubMedGoogle Scholar
• Inoue K, Nakano S, Zhao B. Osteoclastic microRNAs and their translational potential in skeletal diseases. Semin Immunopathol. 2019;41(5):573–582. doi:10.1007/s00281-019-00761-4
   PubMed Web of Science ®Google Scholar
• Sugatani T, Vacher J, Hruska KA. A microRNA expression signature of osteoclastogenesis. Blood. 2011;117(13):3648–3657. doi:10.1182/blood-2010-10-311415
   PubMed Web of Science ®Google Scholar
• Gu C, Xu Y, Zhang S, et al. miR-27a attenuates adipogenesis and promotes osteogenesis in steroid-induced rat BMSCs by targeting PPARgamma and GREM1. Sci Rep. 2016;6(1):38491. doi:10.1038/srep38491
   PubMedGoogle Scholar
• Kim JK, Noh JH, Jung KH, et al. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b. Hepatology. 2013;57(3):1055–1067. doi:10.1002/hep.26101
   PubMed Web of Science ®Google Scholar
• Nishida N, Mimori K, Fabbri M, et al. MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab. Clin Cancer Res. 2011;17(9):2725–2733. doi:10.1158/1078-0432.CCR-10-2132
   PubMed Web of Science ®Google Scholar
• Li R, Li B, Shen M, et al. LncRNA 2310043L19Rik inhibits differentiation and promotes proliferation of myoblast by sponging miR-125a-5p. Aging (Albany NY). 2020;12(7):5625–5639. doi:10.18632/aging.102905
   PubMedGoogle Scholar
• Essandoh K, Li Y, Huo J, Fan GC. MiRNA-mediated macrophage polarization and its potential role in the regulation of inflammatory response. Shock. 2016;46(2):122–131. doi:10.1097/SHK.0000000000000604
   PubMed Web of Science ®Google Scholar
• Wong LL, Armugam A, Sepramaniam S, et al. Circulating microRNAs in heart failure with reduced and preserved left ventricular ejection fraction. Eur J Heart Fail. 2015;17(4):393–404. doi:10.1002/ejhf.223
   PubMed Web of Science ®Google Scholar
• Cai Z, Li J, Zhuang Q, et al. MiR-125a-5p ameliorates monocrotaline-induced pulmonary arterial hypertension by targeting the TGF-beta1 and IL-6/STAT3 signaling pathways. Exp Mol Med. 2018;50(4):45. doi:10.1038/s12276-018-0068-3
   PubMedGoogle Scholar